Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012

Felipe Bellolio Roth1, Javier Gómez2, Jaime Cerda3

  • 1Coloproctology Unit, Department of Digestive Surgery, Pontificia Universidad Católica de Chile, Marcoleta 350, 8320000, Santiago, Chile. fbelloli@med.puc.cl.

Insights

Hospital discharges for inflammatory bowel diseases (IBD) in Chile significantly increased from 2001 to 2012. This trend was accompanied by reduced hospital stays, fewer surgeries, and lower mortality rates for IBD patients.

Area of Science:

  • Gastroenterology
  • Public Health
  • Epidemiology

Background:

  • Inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's disease, represent a significant public health concern.
  • Understanding trends in hospitalizations for IBD is crucial for resource allocation and healthcare planning.

Purpose of the Study:

  • To determine the annual number of hospital discharges for IBD in Chile between 2001 and 2012.
  • To investigate the trend in IBD-related hospitalizations over the study period.

Main Methods:

  • A descriptive study analyzing national hospital discharge data from 2001 to 2012.
  • Key variables examined included length of stay, in-hospital mortality, and surgical procedures.
  • Statistical analysis, including B-coefficient calculation, assessed the significance of the annual trend.

Main Results:

  • A total of 13,001 IBD hospital discharges were recorded, representing 0.067% of all discharges.
  • The annual rate of IBD hospital discharges per 100,000 inhabitants significantly increased from 5.25 in 2001 to 8.64 in 2012.
  • Despite the rise in discharges, there was a notable decrease in length of stay, surgical intervention rates, and in-hospital mortality.

Conclusions:

  • Chile experienced a significant increase in hospital discharges for IBD between 2001 and 2012.
  • This rise in hospitalizations was paradoxically associated with improvements in patient outcomes, including shorter stays and reduced mortality.
  • The findings highlight evolving management strategies and disease patterns for IBD in Chile.
Abstract

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
853
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
972
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
860
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
780